Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison P Wheeler

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Paediatric Anaesthesia|October 9, 2018
Dilutional coagulopathy in pediatric scoliosis surgery: A single center reportCourtney E Baker, Tanya Marvi, Thomas M Austin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 30, 2026
Treatment of Haemophilia A Without Inhibitors: Real-World Treatment Patterns and Clinical Outcomes in the USAllison P Wheeler, Lauren E Amos, Shveta Gupta, et al.
Transfusion|May 10, 2021
Pediatric resident knowledge of transfusion medicine: Results from the BEST-TEST3 international education needs assessmentAllison P Wheeler, Meghan Delaney, Mark Fung, et al.
Blood Advances|March 15, 2022
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitorsAmy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, et al.
Blood|August 25, 2019
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial resultsAmy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, et al.
British Journal of Haematology|January 31, 2024
Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic reviewJeremy W Jacobs, Deva Sharma, Laura D Stephens, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 5, 2025
Real-World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End-of-Study Results From the explorer6 Non-Interventional StudyAllison P Wheeler, Aby Abraham, Chris Barnes, et al.
The Lancet. Haematology|March 1, 2024
Gender composition and geographical representation of American Society of Hematology clinical practice guideline authorsJeremy W Jacobs, Amarilis A Martin, Laura D Stephens, et al.
Blood Vessels, Thrombosis & Hemostasis|July 1, 2026
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 studyTammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, et al.
The Lancet. Haematology|November 9, 2024
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trialPratima Chowdary, Pantep Angchaisuksiri, Shashikant Apte, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Paediatric Anaesthesia|October 9, 2018
Dilutional coagulopathy in pediatric scoliosis surgery: A single center reportCourtney E Baker, Tanya Marvi, Thomas M Austin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 30, 2026
Treatment of Haemophilia A Without Inhibitors: Real-World Treatment Patterns and Clinical Outcomes in the USAllison P Wheeler, Lauren E Amos, Shveta Gupta, et al.
Transfusion|May 10, 2021
Pediatric resident knowledge of transfusion medicine: Results from the BEST-TEST3 international education needs assessmentAllison P Wheeler, Meghan Delaney, Mark Fung, et al.
Blood Advances|March 15, 2022
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitorsAmy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, et al.
Blood|August 25, 2019
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial resultsAmy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, et al.
British Journal of Haematology|January 31, 2024
Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic reviewJeremy W Jacobs, Deva Sharma, Laura D Stephens, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 5, 2025
Real-World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End-of-Study Results From the explorer6 Non-Interventional StudyAllison P Wheeler, Aby Abraham, Chris Barnes, et al.
The Lancet. Haematology|March 1, 2024
Gender composition and geographical representation of American Society of Hematology clinical practice guideline authorsJeremy W Jacobs, Amarilis A Martin, Laura D Stephens, et al.
Blood Vessels, Thrombosis & Hemostasis|July 1, 2026
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 studyTammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, et al.
The Lancet. Haematology|November 9, 2024
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trialPratima Chowdary, Pantep Angchaisuksiri, Shashikant Apte, et al.
Pageof 7